ECM

Mitratech Adds Advanced Document Automation to Its Legal and Compliance Platform with Strategic Acquisition of HotDocs

Retrieved on: 
måndag, juni 10, 2024
Acquisition, Automatic summarization, Automation, CRM, AWS, Risk, Growth, HR, HotDocs, BPM, Snowflake, GRC, API, Partnership, ECM, Conference, Interact

AUSTIN, Texas, June 10, 2024 (GLOBE NEWSWIRE) -- Mitratech, a global compliance technology leader for legal, risk, and HR teams, is excited to announce its strategic acquisition of HotDocs, the market-leading provider of automated document creation and management.

Key Points: 
  • AUSTIN, Texas, June 10, 2024 (GLOBE NEWSWIRE) -- Mitratech, a global compliance technology leader for legal, risk, and HR teams, is excited to announce its strategic acquisition of HotDocs, the market-leading provider of automated document creation and management.
  • The transition brings HotDocs’ decades of market prowess in document assembly into Mitratech's award-winning compliance portfolio.
  • "When you think of the brand that’s most trusted for streamlining the complexity of document production, you think of HotDocs," said Mitratech CEO Mike Williams.
  • Meanwhile, lines of business systems can be seamlessly integrated into HotDocs to bring efficient document automation capabilities to BPM, CRM, ECM, and other business-critical applications.

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

Retrieved on: 
torsdag, juni 6, 2024
Congress, Communication, Extracellular matrix, Conditional sentence, Pharmacology, Trial of the century, Form, Risk, Therapy, Fibroblast, Psoriasis, ECM

HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that Chief Scientific Officer, Hamid Khoja, Ph.D., will present on FibroBiologics’ wound care and psoriasis programs at the Extracellular Matrix (ECM) Pharmacology Congress in Copenhagen, Denmark, from June 17-19, 2024.

Key Points: 
  • HOUSTON, June 06, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that Chief Scientific Officer, Hamid Khoja, Ph.D., will present on FibroBiologics’ wound care and psoriasis programs at the Extracellular Matrix (ECM) Pharmacology Congress in Copenhagen, Denmark, from June 17-19, 2024.
  • The ECM Pharmacology Congress is a forum to bring leading experts across borders and generations together to discuss how to modulate the ECM in different disease areas.
  • Dr. Khoja said, “We will present at the conference our progress in leveraging the capabilities of fibroblasts in extracellular matrix remodeling, which demonstrates the potential for fibroblast-derived therapies to transform the treatment landscape for chronic diseases, including psoriasis and wound care.
  • Recognizing fibroblasts as a vital component of the extracellular matrix, we are developing treatments to harness their regenerative and immunomodulatory capabilities to pave the way for potentially groundbreaking advancements for patients.”
    Details of the presentations are as follows:
    For more information, please visit FibroBiologics' website or email FibroBiologics at: [email protected] .

Critical Metals Corp. Receives BMW Pre-Payment for the Wolfsberg Lithium Project

Retrieved on: 
onsdag, juni 5, 2024
Lithium, BMW, Lithium hydroxide, Gesellschaft mit beschränkter Haftung, Mineral, Partnership, ECM, CRML

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp”), a leading mining development company focused on critical metals and minerals for the green energy transition, today announced that Bayerische Motoren Werkte Aktiengesellschaft (BMW) has transferred funds of US$15 million to ECM Lithium AT GmbH (ECM), a wholly owned subsidiary of Critical Metals Corp.

Key Points: 
  • NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp”), a leading mining development company focused on critical metals and minerals for the green energy transition, today announced that Bayerische Motoren Werkte Aktiengesellschaft (BMW) has transferred funds of US$15 million to ECM Lithium AT GmbH (ECM), a wholly owned subsidiary of Critical Metals Corp.
  • This payment is in relation to the offtake of battery grade lithium hydroxide (LiOH) from the Wolfsberg Lithium Project in Austria which is to be offset against lithium hydroxide delivered to BMW.
  • “We are pleased to move our partnership with BMW forward and look forward to supporting the production of their electric vehicles in Europe in the years to come, contributing to a more sustainable and domestic battery supply chain,” said Tony Sage, CEO and Executive Chairman of Critical Metals Corp. “This pre-payment further strengthens our balance sheet and will allow us to further advance our development strategy.”

B. Hepworth to Launch Gearless Drive Maritime Axial Motor Solution via ECM’s PrintStator Motor CAD SaaS Platform

Retrieved on: 
tisdag, juni 11, 2024
Technology, EV, Electric Vehicles, Vehicle Technology, Automotive, General Automotive, Automotive Manufacturing, Software, Manufacturing, Hardware, Electronic Design Automation, PCB, Stator, HVAC, Marketing, Consumer electronics, United States Navy, Partnership, ECM, Robotics

Per the collaboration, B. Hepworth will leverage ECM’s award-winning Motor CAD optimization platform, PrintStator .

Key Points: 
  • Per the collaboration, B. Hepworth will leverage ECM’s award-winning Motor CAD optimization platform, PrintStator .
  • B. Hepworth has successfully begun production of a commercial windshield wiper product that will enter markets in the first quarter of 2025.
  • Headquartered in the UK, with a US based subsidiary, B. Hepworth brings over 70 years of experience in designing high performance marine wiper systems.
  • ECM has earned 14 award distinctions for its Motor CAD platform and electric motor solutions, including winning the 2024 Automate Innovation Awards for Software.

OpenText Cloud for Government Solution Achieves FedRAMP Authorization

Retrieved on: 
fredag, juni 14, 2024
Cloud, EVP, Fortify, Public sector, Unitary state, Research, Federation, Automation, FedRAMP, Government, OpenText, TSX, Information management, CMDB, Cloud computing, Project, API, ECM, IDC, Government agency

WATERLOO, ON, June 14, 2024 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX), (TSX: OTEX), the information company™, today announced it has achieved "fully authorized" status by the Federal Risk and Authorization Management Program (FedRAMP) for its Cloud for Government solution in the United States which now includes OpenText Extended ECM and OpenText AppWorks, two core products within the OpenText Content Cloud portfolio. The FedRAMP program promotes the adoption of secure cloud services across the federal government by providing a standardized approach to security authorization for cloud service offerings.

Key Points: 
  • WATERLOO, ON, June 14, 2024 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX), (TSX: OTEX), the information company™, today announced it has achieved "fully authorized" status by the Federal Risk and Authorization Management Program (FedRAMP) for its Cloud for Government solution in the United States which now includes OpenText Extended ECM and OpenText AppWorks , two core products within the OpenText Content Cloud portfolio.
  • The FedRAMP program promotes the adoption of secure cloud services across the federal government by providing a standardized approach to security authorization for cloud service offerings.
  • FedRAMP plays a crucial role in enabling the adoption of cloud computing within the federal government while ensuring the security and protection of sensitive data.
  • The Cloud for Government solution offers government agencies a bundled solution to deliver digital cloud services.

Global Enterprise Content Management Strategic Business Report 2024: Connected Enterprises Remain the Cornerstone for Growth - Market to Reach $133.7 Billion by 2030 from $60 Billion in 2023 - ResearchAndMarkets.com

Retrieved on: 
tisdag, juni 4, 2024
Software, Technology, Data Management, Automation, Data management, Growth, Enterprise content management, ECM, Service, Printed circuit board

The "Enterprise Content Management - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Enterprise Content Management - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The global market for Enterprise Content Management, estimated at US$60.7 Billion in the year 2023, is projected to reach a revised size of US$133.7 Billion by 2030, growing at a CAGR of 10.4% over the analysis period 2023-2030.
  • Enterprise Content Management Solutions, one of the segments analyzed in the report, is projected to record 9.7% CAGR and reach US$97.1 Billion by the end of the analysis period.
  • The ongoing digitalization and emergence of new technologies are significantly driving the adoption of Enterprise Content Management (ECM) systems.

Front End of the Line Semiconductor Equipment Market size is set to grow by USD 7.55 billion from 2024-2028, Growth of advanced consumer electronics industry to boost the market growth, Technavio

Retrieved on: 
torsdag, juni 13, 2024
IDM, GPS, Lam Research, SUSS, Silicon, Sumitomo Corporation, ALD, 3D, CVD, ABS, ASML, Memory, Car, Automation, Stepper, FEOL, PECVD, Foundry, Hitachi, Sample, Professional corporation, Growth, Research report, ECM, Applied Materials, Toyota, Consumer electronics

The Front End of the Line Semiconductor Equipment Market is poised for growth due to the increasing demand for electronic content in automobiles.

Key Points: 
  • The Front End of the Line Semiconductor Equipment Market is poised for growth due to the increasing demand for electronic content in automobiles.
  • With the rise in car production, the demand for semiconductor devices follows, subsequently boosting the market for front-end semiconductor equipment.
  • The Front End of the Line semiconductor equipment market is experiencing significant trends.
  • For more details- Download a Sample Report
    The Front End of the Line Semiconductor Equipment Market faces significant challenges due to the high cost of advanced equipment.

NextCure Presents Phase 1b Data on NC410 and Pembrolizumab Combination at ASCO 2024

Retrieved on: 
torsdag, maj 30, 2024
ICI, Patient, Liver disease, Pembrolizumab, Ovarian cancer, TME, Colorectal cancer, MSI-L, ECM, Safety, Diarrhea, MSS, PRS, Assistant, Cancer, Infiltration, ASCO, CRC, Fatigue, Society, Aes, Immunotherapy, DCR, Annual general meeting, Johns Hopkins, Pharmaceutical industry

The poster presentation highlights the safety and tolerability of doses between 30-200 mg of NC410 in combination with 400 mg of pembrolizumab.

Key Points: 
  • The poster presentation highlights the safety and tolerability of doses between 30-200 mg of NC410 in combination with 400 mg of pembrolizumab.
  • The combination resulted in partial responses (PR) and stable disease in both CRC and ovarian cancer.
  • “While MSS/MSI-L CRC and ovarian cancer are difficult to treat and recalcitrant to immunotherapy, the combination of NC410 and pembrolizumab demonstrated clinical activity against both tumor types.
  • Details of the presentation are as follows:
    Title: A Phase 1b study of NC410 in combination with pembrolizumab in immune checkpoint inhibitor (ICI) naïve, and refractory microsatellite stable (MSS)/microsatellite instability-low (MSI-L) colorectal cancer (CRC) and ovarian cancer

Fusion BPM and ECM Platform Expand to the North American Market in Partnership with S4A IT Solutions

Retrieved on: 
onsdag, maj 22, 2024
Partnership, Automation, Organization, BPMS, Business, BPM, ECM, Public sector, Risk management, Business process management, Enterprise content management, 3D printing

This expansion is backed by a strategic partnership with S4A IT Solutions, a leading Calgary-based boutique IT solutions and delivery consulting company.

Key Points: 
  • This expansion is backed by a strategic partnership with S4A IT Solutions, a leading Calgary-based boutique IT solutions and delivery consulting company.
  • "After experiencing exponential growth in South America, we are excited to bring Fusion to the North American market," states Farley Niehues, COO of Neomind Solutions.
  • S4A IT Solutions, known for its commitment to innovation, excellence, and superior client satisfaction, is enthusiastic about the collaboration with Neomind and its Fusion platform software product.
  • "We see tremendous potential in Fusion’s ability to drive innovation and efficiency for businesses in North America," says Elisandro Porto, CEO of S4A IT Solutions.

A Bold Step Forward: Trial Equity and Miller Tanner Associates Partner to Champion Diversity in Clinical Research

Retrieved on: 
onsdag, maj 22, 2024
ChromeOS, Partnership, Education, Drug development, Clinical trial, Virtual, ECM, National Council, Associate, Curriculum, MTA, Equity, Nursing

MTA will further empower healthcare professionals (HCPs) to implement diversity in clinical trials by offering Trial Equity’s vital diversity workshops at Investigator Meetings.

Key Points: 
  • MTA will further empower healthcare professionals (HCPs) to implement diversity in clinical trials by offering Trial Equity’s vital diversity workshops at Investigator Meetings.
  • "Partnering with Miller Tanner Associates was a strategic choice, driven by their deep expertise in life sciences and masterful event planning,” shared Dr. Otis Johnson, Co-founder, Trial Equity.
  • “Their innovative VALTs platform and extensive global experience are key to effectively delivering our Clinical Trial Diversity Training worldwide.
  • “MTA is proud to partner with Trial Equity to meet the evolving needs of our customers with this new service offering and drive meaningful transformation of our industry.”
    Together, Trial Equity and Miller Tanner Associates are setting new standards in clinical trial diversity, paving the way for a future where medical research is truly inclusive.